Today, the U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids. In an updated safety communication, originally issued in April 2014, the FDA warns against using laparoscopic power morcellators in the removal of the uterus (hysterectomy) or fibroids (myomectomy) in the vast majority of women.
A new study shows that as many as one-third of all tumors revealed by mammograms may be benign, and focus on mammography may have resulted in the overdiagnosis of breast cancer in more than a million women in the past 30 years. However, avoiding mammograms may lead to failure to diagnose malignant cancers as well.The study purports that rising breast cancer survival rates are more likely due to improvements in treatment rather than screening. The author argues that the overuse of mammograms results in the identification of non-threatening tumors; these diagnoses then subject 70,000 women per year to needless surgery. The improvements in screening have led to the identification of previously missed tumors that, in the past, would have been left alone and would not have caused illness, according to the study. Detractors of the study claim that this theory is part of a campaign to cut back on screening tests in an effort to reduce healthcare costs.
Unfortunately, even obvious symptoms can be missed by physicians. For this reason, patients from Ohio and Kentucky can always use a second opinion if they suspect something is being missed or misdiagnosed. One illness that is increasingly being misdiagnosed among patients under the age of 50 is cancer - in particular colorectal cancer.
It should never be assumed that patients will prevail in every medical malpractice action. Such lawsuits are complex, and trying such a case often requires an attorney to jump over a number of legal hurdles.